PM360

OCTOBER 28, 2022

Two of ZS’ major studies suggest that the trend towards more advanced KAM strategies and capabilities will continue to accelerate for pharma manufacturers. Despite these organizations’ size, pharma sales representatives remain severely constrained in their ability to reach the physicians who prescribe our products.

Key account management 117

Key account management Pharma Management Pharma sales reps 117

PM360

AUGUST 24, 2023

Most market access teams at pharmaceutical and biotech manufacturers have the same problem: evidence of clinical effectiveness isn’t always enough to affect prescribing behavior, often due to—accurate or misperceived—access and affordability concerns. Seamless integration with core data and systems.

Pharma 98

Pharma Physicians Marketing Insurance 98

Clarivate

JULY 5, 2023

In 2022, it made its manufacturer, AbbVie, $21.2bn. This strategy is often chosen by the brand manufacturers who offer higher rebates at the net price level in exchange for better placement on formularies. The Biosimilars Forum has hailed 2022 as a watershed year that could create a more competitive U.S. The current U.S.

Marketing 97

Marketing Physicians Manufacturing Competition 97

World of DTC Marketing

MARCH 23, 2022

Patients trust their doctors, so the accelerated approval process must be modified to increase their trust with physicians and explain to patients precisely what accelerated drug approval means. Do patients care? The answer to that would be “no.” of approvals), cancer (35.6%), and other rare diseases (24.7%).

Patients 200

Patients FDA Doctors Physicians 200

PM360

MAY 15, 2023

Ultimately, she helps industry utilize technology that connects the ecosystem from the manufacturer, pharmacy, hub, and payer to bring therapies to patients. Karina joined OptimizeRx in 2021, where she has increased the digitalization of access to help move drug manufacturers away from manual processes.

Physicians 59

Physicians Electronics Prescription Manufacturing 59

Scott’s Directories

JUNE 8, 2023

Unlocking Opportunities: Nova Scotia Physician Directory The Nova Scotia physician directory, another vital component of MD Select ‘s resources, is an indispensable tool for businesses seeking to connect with physicians in the region. Here are some strategies to consider: a.

Medical 52

Medical Marketing Doctors Physicians 52

European Pharmaceutical Review

MAY 3, 2023

The Phase III trial results demonstrated “the benefit of using a CAR T-cell therapy earlier” for relapsed or refractory DLBCL patients, added Dr Bertram Glass, TRANSFORM trial investigator and Chief Physician of the Department of Hematology and Stem Cell Transplantation, Helios Klinikum, Berlin, Germany.

Manufacturing 88

Manufacturing Physicians Patients Pharmaceutical 88

Clarivate

MAY 1, 2024

GLP-1s will offer an attractive option to patients hesitant to undergo an invasive surgical procedure, and manufacturers like Medtronic and Johnson & Johnson anticipate a temporary dip in surgery volumes.

Side effects 59

Side effects Physicians Medical Patients 59

MedCity News

APRIL 17, 2024

The recall comes years after surgeons say they first noticed problems with the HeartMate II and HeartMate 3, manufactured by Thoratec Corp., a subsidiary of Abbott Laboratories. The devices are not currently being removed from the market.

FDA 90

FDA Manufacturing Marketing Physicians 90

PM360

JULY 26, 2023

To prepare for the second order effects of the IRA, one important step that we recommend for manufacturers is to clearly articulate and outline the remaining uncertainties regarding how the IRA will be implemented by CMS and identify scenarios most likely to impact their products. Acceptance and Consideration of Manufacturer Evidence.

Manufacturing 98

Manufacturing Pharma Competition Distribution 98

Scott’s Directories

JUNE 14, 2023

With a comprehensive list of clinics, hospitals, pharmaceutical companies, medical placement firms, distributors, manufacturers of medical equipment and supplies, as well as physicians, surgeons, and nurse practitioners, the directory caters to various medical information needs.

Healthcare 52

Healthcare Healthcare Doctors Physicians 52

PM360

JULY 13, 2023

Look to the Medication Experts to Help with Polypharmacy Reaching prescribers such as physicians is crucial to getting patients on therapy; however, physicians may not have the full view of a patient’s regimen. 14 Plus, 30% of people with chronic conditions do not see a primary care physician at all.

Prescription 52

Prescription Medical Physicians Education 52

Pharmaceutical Technology

MAY 26, 2023

According to the findings, 39% of surveyed high-prescribing physicians believe that the optimal place for immune-oncology agents is in a first-line setting. The surveyed physicians believed that both newly-diagnosed, and treatment-refractory patients are the most likely to benefit from such therapies.

Marketing 105

Marketing Physicians Insurance Pharmaceutical 105

PM360

MARCH 24, 2023

states are now collecting pricing data from manufacturers in the hopes it will assist in creating effective policies to reduce drug prices for their constituents. The Sunshine Act years ago pushed the states to begin monitoring payments and other transfers of value to physicians and teaching hospitals.

Manufacturing 96

Manufacturing Retail Management Distribution 96

PM360

JULY 26, 2022

Physicians Need More Education. As healthcare marketers, we can support physicians in this effort by raising awareness of the LGBTQ+ screening gap and by providing tactical support,” she says. “For

Patients 97

Patients Pharma Physicians Education 97

World of DTC Marketing

NOVEMBER 5, 2021

” One has to wonder if physicians are warning patients that Wegovy is NOT a miracle cure for obesity but must be taken with a strict diet and increased exercise. Nearly 3% of the overall U.S. The reasons are complex. Many factors contribute to obesity. In that case, much of the surplus energy will be stored by the body as fat.”

Insurance 271

Insurance Side effects Prescription Medical 271

pharmaphorum

JUNE 27, 2022

7008), which allows manufacturers to share vital information with healthcare payers and plans while treatments are pending Food and Drug Administration (FDA) approval, was passed by the House of Representatives and is awaiting approval in the Senate. The AMCP backed bill (H.R. The AMCP backed bill (H.R. The history of PIE.

Food and Drug Administration 80

Food and Drug Administration Medical Patients FDA 80

World of DTC Marketing

JUNE 23, 2021

Therefore, I find it hard to understand how so many physicians could show “strong interest” in prescribing a drug with so many questions vs. answers. I always thought if there were questions about efficacy or treatment, we should be overly cautious and inform our customers (patients). government.

FDA 218

FDA Side effects Physicians Patients 218

PM360

APRIL 7, 2023

In the near term, manufacturers may need to reconsider price increase strategy given inflation penalties for Medicare beneficiaries. Reduced patient out-of-pocket (OOP) costs in Part D have the potential to reduce beneficiary reliance on foundation support, with commensurate reductions in manufacturer donations required.

Manufacturing 97

Manufacturing Insurance Government Marketing 97

PM360

SEPTEMBER 21, 2023

The recent wave of Alzheimer’s Disease (AD) drug approvals and promising pivotal trial data from various drug manufacturers has been celebrated by physicians, patients, caregivers, and advocacy groups across the U.S. It’s important for drug manufacturers to take a step back and view this CMS decision as a learning opportunity.

Manufacturing 99

Manufacturing FDA Recruitment Prospecting 99

Clarivate

OCTOBER 25, 2023

What the addition of Part B may bring With the expansion of price negotiations to include Part B drugs in 2028 , Medicare reimbursement may become challenging for additional manufacturers. Unlike in Part D, Part B drugs are physician administered and there is less certainty regarding which drugs will be tapped for negotiations (i.e.,

Prescription 52

Prescription Physicians Manufacturing Healthcare 52

European Pharmaceutical Review

DECEMBER 1, 2023

This interview explores the innovations in biologics delivery, as well as the emergence of new modalities and the shift to continuous manufacturing. AK : Prefilled syringes are definitely more patient friendly, as patients can take them home and self-administer without needing a physician or a pharmacist.

Food and Drug Administration 83

Food and Drug Administration Manufacturing Pharma Patients 83

pharmaphorum

SEPTEMBER 15, 2022

Mallinckrodt has finally claimed FDA approval for terlipressin as a treatment for hepatorenal syndrome (HRS), after manufacturing problems scuppered an earlier attempt. The drug is already approved for this indication in dozens of other countries around the world, including much of Europe, Australia and New Zealand.

FDA 92

FDA Manufacturing Physicians Leads 92

World of DTC Marketing

FEBRUARY 7, 2021

Drug Discovery and Manufacturing: It helps in the initial screening of drug compounds to the predicted success rate based on biological factors. AI may predict the questions patients and physicians have about a drug or its side effects. Measuring RNA, DNA quickly. So how can AI help DTC marketers?

Pharma 164

Pharma Doctors Side effects Physicians 164

Pharmaceutical Technology

JULY 20, 2022

Previously, only licensed and authorised physicians, advanced practice registered nurses, and physician assistants could prescribe the drug. . The updated guidance still mandates a patient to be referred to a physician or other healthcare professionals if this information is not available.

Food and Drug Administration 111

Food and Drug Administration Physicians Prescription Medical 111

World of DTC Marketing

APRIL 14, 2021

BMS believes they price our medicines based on the value they deliver,” but physicians say the price is too high. The main US industry lobby group Pharmaceutical Research and Manufacturers of America (PhRMA) says : “On average, it takes 10-15 years and costs $2.6 FOLLOW PROFIT, NOT NEED. Which explains that 20% profit margin.

Pharma 191

Pharma Prospecting Transportation Retail 191

Scott’s Directories

NOVEMBER 15, 2022

If you’re looking to improve your medical device sales, here are some tips to help you get started including using the list of physicians in Saskatchewan. Using the Saskatchewan physician directory can help develop targeted pitches. Contact MD Select today to try our database and improve your Saskatchewan physician search.

Medical 52

Medical Sales Physicians Competition 52

PM360

APRIL 7, 2023

Now that Medicare covers the therapy, manufacturer AppliedVR hopes that commercial health plans, self-insured employers, and other payers will consider covering the program. physicians are reporting feeling even more burnout (49%) in 2023 than they were in 2022 (45%). One in three (33%) U.S. While 20% of U.S. In the U.S.,

Healthcare 52

Healthcare Healthcare Insurance Physicians 52

Pharmaceutical Technology

MARCH 24, 2023

AbbVie had reached settlement agreements with the biosimilar manufacturers to keep the biosimilars off the US market until 2023. The Humira settlements involved a deal where the biosimilar manufacturers delayed entry and pay AbbVie a royalty upon launch. Many other biosimilars have also been FDA-approved since 2016.

Competition 59

Competition Marketing FDA Physicians 59

European Pharmaceutical Review

NOVEMBER 8, 2022

For example, the US recently passed the Inflation Reduction Act, 1 which requires the Secretary of Health and Human Services (HHS) to negotiate prices for certain physician-administered and retail prescription drugs covered under Medicare Parts B and D. 3) policing anticompetitive settlements between competing drug manufacturers.

Food and Drug Administration 52

Food and Drug Administration Pharma Prescription Manufacturing 52

Pharmaceutical Technology

SEPTEMBER 7, 2022

Many companies use artificial intelligence (AI) to enable pharmaceutical manufacturers to overcome barriers to medication adherence. They also partner with retail pharmacy chains, pharmacy network aggregators, and consumer behaviour data companies on behalf of pharmaceutical manufacturers to collect data for sourcing patient information.

Leads 52

Leads Pharmaceutical Patients Pharmaceutical manufacturing 52

European Pharmaceutical Review

FEBRUARY 8, 2023

However, Warburton stated, it is “currently unclear whether or not the companies’ manufacturing capabilities will be able to withstand the increased demand; if not, this may cap the number of patients treated with these agents.”

Marketing 94

Marketing Sales Physicians Patients 94

European Pharmaceutical Review

DECEMBER 19, 2023

This requires the development of technologies to rapidly produce effective, safe, stable vaccines that can be manufactured and distributed quickly. Guaranteeing resilience in vaccine manufacturing The use of foreign materials that require removal before injection are also impracticable.

Distribution 99

Distribution Manufacturing Food Specialization 99

Pharmaceutical Technology

MAY 2, 2023

High-prescribing physicians surveyed by GlobalData across eight major markets (8MM: US, France, Germany, Italy, Spain, UK, Japan, and China) identified a broad range of unmet needs in the IO space (see Figure 1). Despite the significant advances that have been made in the IO field, a huge level of unmet need remains.

Physicians 52

Physicians Marketing Patients Manufacturing 52

World of DTC Marketing

AUGUST 12, 2022

Among the 25 worldwide companies that spend the most on research and development—all more than $5 billion a year—seven are pharmaceutical manufacturers, but eight are automobile or automobile parts companies with profit margins under 10 percent. Amazon’s operating margin is under 5 percent.

Pharma 255

Pharma Retail Pharmaceutical manufacturing Pharmaceutical 255

PM360

DECEMBER 14, 2023

Chief among them is the now proven mRNA vaccine technology, which can be used to develop safe and effective vaccines with remarkable speed that can be rapidly manufactured at scale.” Additionally, MedCentral offers diversity topics and points of view to ensure clinicians find the support they need.

Physicians 52

Physicians Pharma Medical Patients 52

Clarify Health

JANUARY 12, 2022

Robust clinical and economic RWE can support value-based pricing and innovative risk-sharing contracts for medical device manufacturers. Clarify has supported genetic testing companies, digital therapeutics manufacturers, and device companies across varying therapeutic areas, including women’s health, oncology, and behavioral health.

Medical 52

Medical Physicians Marketing Education 52